nivolumab
bms
['melanoma', 'opdivo', 'nivo', 'nivolumab', 'check,mate,76k', '$bmy', 'bristol']
#bristolmyerssquibb presents data from #checkmate76k showing #opdivo (#nivolumab) reduced the risk of recurrence or death by 58% versus #placebo in patients with completely resected stage iib or iic #melanoma $bmy 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.